B.E. de Galan

Fabricius, T. W., Verhulst, C., Svensson, C. H., Wienberg, M., Duijnhouwer, A. L., Tack, C. J., Kristensen, P. L., de Galan, B. E., Pedersen-Bjergaard, U., & Hypo-RESOLVE Consortium (2025). Effects of insulin-induced hypoglycaemia on cardiac function in people with type 1 and type 2 diabetes and people without diabetes. Diabetes Obesity & Metabolism, 27(5), 2768-2776. https://doi.org/10.1111/dom.16283

Steens, I. L. M., Ji, Y., Sedaghat, S., Pankow, J., Klein, B. E. K., Cotch, M. F., Mcclelland, R. L., Hayden, K. M., Hughes, T. M., Bancks, M. P., Houben, A. J. H. M., Kroon, A. A., Koster, A., Bosma, H., Berendschot, T. T. J. M., de Galan, B. E., & van Sloten, T. T. (2025). Diabetes and incident stroke and mediation by microvascular dysfunction: Pooled analysis of three population-based studies. Diabetes Obesity & Metabolism, 27(4), 2299-2304. Article 16217. https://doi.org/10.1111/dom.16217

Albers, J., Koster, A., Sezer, B., Meisters, R., Chan, J., Wesselius, A., Schram, M., de Galan, B., Lakerveld, J., & Bosma, H. (2025). Socioeconomic position and type 2 diabetes: Examining the mediating role of social cohesion—The Maastricht Study. Social Science & Medicine, 376, Article 118046. Advance online publication. https://doi.org/10.1016/j.socscimed.2025.118046

Tokgöz, S., Boss, M., Jansen, T. J., Meijer, R., Frielink, C., van Bon, A. C., Tack, C. J., de Galan, B. E., & Gotthardt, M. (2025). Activation of the HPA axis does not explain non-responsiveness to GLP-1R agonist treatment in individuals with type 2 diabetes. Diabetes, 74(2), 212-222. https://doi.org/10.2337/db24-0463

Drenthen, L. C. A., Ajie, M., de Baaij, J. H. F., Tack, C. J., de Galan, B. E., & Stienstra, R. (2024). Magnesium supplementation modulates T-cell function in people with type 2 diabetes and low serum magnesium levels. Journal of Clinical Endocrinology & Metabolism, 109(12), e2240-e2245. Article dgae097. https://doi.org/10.1210/clinem/dgae097

Castañeda, J., de Galan, B. E., van Kuijk, S. M. J., Arrieta, A., van den Heuvel, T., & Cohen, O. (2024). The interdependence of targets for continuous glucose monitoring outcomes in type 1 diabetes with automated insulin delivery. Diabetes Obesity & Metabolism, 26(12), 5836-5844. https://doi.org/10.1111/dom.15955

Heyens, L., Kenjic, H., Dagnelie, P., Schalkwijk, C., Stehouwer, C., Meex, S., Kooman, J., Bekers, O., van Greevenbroek, M., Savelberg, H., Robaeys, G., de Galan, B., Koster, A., van Dongen, M., Eussen, S., & Koek, G. (2024). Forns index and fatty liver index, but not FIB-4, are associated with indices of glycaemia, pre-diabetes and type 2 diabetes: analysis of The Maastricht Study. BMJ Open Gastroenterology, 11(1), Article e001466. https://doi.org/10.1136/bmjgast-2024-001466

Meisters, R., Koster, A., Albers, J., Sezer, B., van Greevenbroek, M., de Galan, B., & Bosma, H. (2024). Early life socioeconomic inequalities and type 2 diabetes incidence: Longitudinal analyses in the Maastricht study. Diabetes Research and Clinical Practice, 217, Article 111855. https://doi.org/10.1016/j.diabres.2024.111855

Jansen, T. J. P., Tokgoz, S., Buitinga, M., van Lith, S. A. M., Joosten, L., Frielink, C., Smeets, E. M. M., Stommel, M. W. J., van der Kolk, M. B., de Galan, B. E., Brom, M., Boss, M., & Gotthardt, M. (2024). Validation of radiolabelled exendin for beta cell imaging by ex vivo autoradiography and immunohistochemistry of human pancreas. EJNMMI Research, 14(1), Article 96. https://doi.org/10.1186/s13550-024-01159-6

Divilly, P., Martine-Edith, G., Zaremba, N., Søholm, U., Mahmoudi, Z., Cigler, M., Ali, N., Abbink, E. J., Brøsen, J., de Galan, B., Pedersen-Bjergaard, U., Vaag, A. A., McCrimmon, R. J., Renard, E., Heller, S., Evans, M., Mader, J. K., Amiel, S. A., Pouwer, F., ... Hypo-RESOLVE Consortium (2024). Relationship Between Sensor-Detected Hypoglycemia and Patient-Reported Hypoglycemia in People With Type 1 and Insulin-Treated Type 2 Diabetes: The Hypo-METRICS Study. Diabetes Care, 47(10), 1769-1777. https://doi.org/10.2337/dc23-2332